There are preclinical studies in which vaccination with a plasmid carrying a plasmid encoding an ALK related protein in a mouse model of ALK positive lymphoma induced the generation of specific CD8 + CTLs and γ- Interferons, and ultimately effectively suppressed the local progression and distant metastasis of lymphoma. This evidence concerns the gene ALK and lymphoma.